These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Tricky FDA debate: should a risky drug be approved again? Mathews AW; Westphal SP Wall St J (East Ed); 2006 Feb; ():B1, B4. PubMed ID: 16528879 [No Abstract] [Full Text] [Related]
24. The black box warning. Abourjaily HM; Rosenberg M J Mass Dent Soc; 2002; 51(3):54-6. PubMed ID: 12380043 [No Abstract] [Full Text] [Related]
25. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment. Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625 [TBL] [Abstract][Full Text] [Related]
26. Drug research and children. Meadows M FDA Consum; 2003; 37(1):12-7. PubMed ID: 12625300 [No Abstract] [Full Text] [Related]
27. What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling. Willy ME; Li Z Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):201-6. PubMed ID: 15255086 [TBL] [Abstract][Full Text] [Related]
28. From black boxes to screening guidelines and antibiotic use: what is it all about? Resnick B Geriatr Nurs; 2007; 28(3):143-4. PubMed ID: 17561011 [No Abstract] [Full Text] [Related]
29. Paediatric clinical trials: redressing the imbalance. Schreiner MS Nat Rev Drug Discov; 2003 Dec; 2(12):949-61. PubMed ID: 14654794 [No Abstract] [Full Text] [Related]
30. Requirements on content and format of labeling for human prescription drug and biological products. Final rule. Food and Drug Administration, HHS Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698 [TBL] [Abstract][Full Text] [Related]
31. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
32. Improving how we evaluate the toxicity of approved drugs. Reidenberg MM Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311 [No Abstract] [Full Text] [Related]
33. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule. Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526 [TBL] [Abstract][Full Text] [Related]
34. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691 [TBL] [Abstract][Full Text] [Related]
35. Should off-label drug use be off-the-table? Rivkees SA J Pediatr Endocrinol Metab; 2007 Feb; 20(2):171-2. PubMed ID: 17396432 [No Abstract] [Full Text] [Related]
36. FDA reform in Congress: AIDS community absent. Food and Drug Administration. James JS AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320 [TBL] [Abstract][Full Text] [Related]
37. New FDA rule affects drug labeling. J Am Vet Med Assoc; 1998 Sep; 213(5):598. PubMed ID: 9731244 [No Abstract] [Full Text] [Related]
39. Are "off-labels" legal? Price EC Mich Health Hosp; 1998; 34(6):20-1. PubMed ID: 10187136 [TBL] [Abstract][Full Text] [Related]
40. A drug is not a drug is not a drug: a commentary. Struijker Boudier HA Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):437-8. PubMed ID: 12426926 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]